Skip to main content
Symbolic photo - Large amounts of data were analyzed for the "Highly Cited Researchers".

Honors & Funding

5 ImmunoSensation Highly Cited Researchers

ImmunoSensation is represented with 5 "Highly Cited Researchers" in Immunology and Cross-Field in this year's international ranking from Clarivate.

According to the creators of the ranking, the individuals on this list of "Highly Cited Researchers" are among the world's most influential one percent of their field.

The benchmark is the frequency with which their scientific publications were cited by other researchers in the past decade (period from 2012t o 2022). The ranking is published annually by the "Web of Science Group" and includes around 7,100 scientists from 67 different countries.

The most cited researchers at ImmunoSensation are:

Thomas Bieber, Cross-Field
Eicke Latz, Immunology
Andreas Schlitzer, Cross-Field
Jonathan L. Schmid-Burgk, Cross-Field
Joachim L. Schultze, Immunology

The University of Bonn is represented with a total of 11 researchers.

Further information: https://recognition.webofscience.com/awards/highly-cited/2023/

Press release University of Bonn: https://www.uni-bonn.de/en/news/213-2023?set_language=en

Related news

Speakers of ImmunoSensation

Honors & Funding

ImmunoSensation goes into the next round

—The Bonn Cluster of Excellence ImmunoSensation will be funded for further seven years as part of the Excellence Strategy of the German federal and state governments. The aim of the new funding period, which begins on January 1, 2026, is to research immune diversity: the structural, functional and dynamic diversity of the immune system. Involved are the University of Bonn, the University Hospital Bonn (UKB) and the German Center for Neurodegenerative Diseases (DZNE). The funding amounts to around 50 million euros.
View entry
Kerstin Ludwig

Honors & Funding

Genome data to improve diagnosis and treatment of long Covid

—Despite the many advances, there are still major gaps in the care of patients with long-term and post-COVID. The Institute of Human Genetics at the UKB in Bonn now begins a genomLC study as part of a BMG funding priority. The researchers want to help speed up the diagnosis of long- and post-COVID and identify possible biomarkers that could possibly also differentiate between subgroups of the diseases. To this end, the genomic data of those affected is being analyzed as part of a study using blood samples. The project is funded by the Federal Ministry of Health (BMG) with 1.34 million euros.
View entry
Reckzeh News

Honors & Funding

Creating Personalized Cancer Treatments

—Bonn researchers aim to improve colon cancer treatment using 3D organoids and digital twins. Funded by the Federal Ministry of Education and Research (BMBF), a collaborative project involving the University of Bonn, the company ESQlabs and the University Hospital Bonn is seeking to refine the therapy recommendations given to colon cancer patients. To this end, “ISPOT-K” is merging organoids taken from patients with the power of digital twin technology.
View entry

Back to the news overview